A cellular gene up-regulated by hepatitis B virus - Encoded X antigen promotes hepatocellular growth and survival

Hepatology

Volumn 34, Issue 1, 2001, Pages 146-157

  Lian, Zhaorui ^a   Liu, Jie ^a   Pan, Jingbo ^a   Satiroglu Tufan, N Lale ^a   Zhu, Minghua ^b   Arbuthnot, Patrick ^c   Kew, Michael ^c   Clayton, Marcy M ^a   Feitelson, Mark A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Second Military Medical College   (China)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HEPATITIS B ANTIGEN; HEPATITIS B X ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ARTICLE; CANCER GROWTH; CHRONIC DISEASE; CONTROLLED STUDY; GENE CONTROL; GENE OVEREXPRESSION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CARCINOMA; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

EID: 0034950567     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.25545     Document Type: Article

References (44)

1. Epidemiology of hepatocellular carcinoma
2. Epidemiological characteristics and risk factors of hepatocellular carcinoma
3. Hepatitis B virus infection and primary hepatocellular carcinoma
4. Loss of heterozygositiy in liver tumours
5. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis. Relationship to disease stage, tumor size, and cirrhosis
6. Hepatitis B x antigen in liver from carrier patients with chronic hepatitis and cirrhosis
7. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer
8. Malignant transformation of immortalized hepatocytes by hepatitis B virus DNA
9. Functional inactivation but not structural mutation of p53 causes liver cancer
10. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
11. Hepatitis B virus X-gene product: A promiscuous transcriptional activator
12. Hepatitis B virus trancriptional activators: Mechanisms and possible role in oncogenesis
13. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions
14. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation
15. The X protein of hepatitis B virus coactivates potent activation domains
16. pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner
17. HBxAg and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma
18. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
19. Direct interaction of the hepatitis B virus HBx protein with p53 response elementdirected transactivation
20. HBV X protein activates ras-GTP complex formation and establishes a ras, raf, MAP kinase signaling cascade
21. Ras- and raf-dependent activation of c-Jun transcriptional activity by the hepatitis B virus transactivator pX
22. HBx protein of hepatitis B virus activates Jak1-STAT signaling
23. HBV transactivator HBx uses a tumour promoter signalling pathway
24. Hepatitis B virus protein activates transcription factor NF-κB without a requirement for protein kinase C
25. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: Implications of IGF-I receptor gene activation by hepatitis B virus X gene product
26. Induction of the DNA binding activity of c-Jun/c-Fos heterodimers by the hepatitis B virus transactivator pX
27. The X-gene of human hepatitis B virus transactivates the c-jun and a-fetoprotein genes
28. Expression of the pancreatic secretory trypsin inhibitor gene in the liver infected with hepatitis B virus
29. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells
30. The hepatitis B virus X protein up-regulates tumor necrosis factor a gene expression in hepatocytes
31. Identification and preliminary characterization of a protein involved in cellular senescence which binds to hepatitis B virus X antigen
32. The translation initiation factor, SUI1, may be a target of hepatitis B x antigen in hepatocarcinogenesis
33. X antigen polypeptides in the sera of hepatitis B virus infected patients
34. GenBank
35. Presence of antibodies to the polymerase gene product(s) of hepatitis B and woodchuck hepatitis virus in natural and experimental infections
36. Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies
37. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls
38. The hepatitis B virus HBx protein inhibits caspase 3 activity
39. The mitochondrial permeability transition augments Fas-induced apoptosis in mouse hepatocytes
40. Characteristics of woodchuck hepatitis X antigen in the livers and sera from chronically infected animals
41. Imvolvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis
42. Embryonic lethality and liver regeneration in mice lacking the Re1A component of NF-κB
43. Hepatitis B x gene expression in hepatocellular carcinoma
44. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma